← Leaderboards
Roslyn B Mannon
Omaha Va Medical Center
$867,736
Attributed
$1,708,811
Total exposure
4
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $346.1K · FY2017–25$500K$375K$250K$125K$0
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$1,708,811 · 2
VA$0 · 2
By mechanism
U01$1,682,150 · 1
K08$26,661 · 1
I01$0 · 2
Top collaborators
- Gaurav Agarwal4 shared
- Bruce A Julian2 shared
Others in their field
Top investigators on “Transplantation”
- Gerald T Nepom · Benaroya Research Inst At Virginia Mason$298,740,071
- Mary M Horowitz · Medical College Of Wisconsin$224,924,548
- Craig B Thompson · Sloan-Kettering Inst Can Research$157,997,949
- Charles A Coltman · Southwest Oncology Group$141,983,231
- Richard L Schilsky · University Of Chicago$117,759,216
- Harold E Varmus · Sloan-Kettering Institute For Cancer Res$82,854,111
Research focus
TransplantationRenal FunctionKidneyAllograftingKidney DiseasesSerumProgramsTransplant RecipientsCreatinineKidney TransplantationFailureGraft SurvivalPharmaceutical PreparationsMedical CenterKidney FailureImmunosuppressionImmunosuppressive AgentsHistologicPost-TransplantReportingTissuesOrganParticipantLead
Grant awards (15)
4/14 APOL1 Long-term Kidney Transplantation Outcomes Network (APOLLO) Clinical Center$306,100
U01 · FY2025 · DK
An Exploratory Investigation of the Safety of Empagliflozin in Kidney Transplant Recipients (SEKTR)$0
I01 · FY2025 · VA · contact PI
4/14 APOL1 Long-term Kidney Transplantation Outcomes Network (APOLLO) Clinical Center$310,000
U01 · FY2024 · DK
An Exploratory Investigation of the Safety of Empagliflozin in Kidney Transplant Recipients (SEKTR)$0
I01 · FY2024 · VA · contact PI
4/14 APOL1 Long-term Kidney Transplantation Outcomes Network (APOLLO) Clinical Center$280,127
U01 · FY2023 · DK
APOL1 Long-term Kidney Transplantation Outcomes Network (APOLLO) Clinical Center$306,450
U01 · FY2022 · DK
AMP Kinase Activation in Calcineurin Inhibitor Nephrotoxicity$0
I01 · FY2021 · VA · contact PI
APOL1 Long-term Kidney Transplantation Outcomes Network (APOLLO) Clinical Center$133,332
U01 · FY2020 · DK
AMP Kinase Activation in Calcineurin Inhibitor Nephrotoxicity$0
I01 · FY2020 · VA · contact PI
AMP Kinase Activation in Calcineurin Inhibitor Nephrotoxicity$0
I01 · FY2020 · VA · contact PI
APOL1 Long-term Kidney Transplantation Outcomes Network (APOLLO) Clinical Center$346,141
U01 · FY2019 · DK
AMP Kinase Activation in Calcineurin Inhibitor Nephrotoxicity$0
I01 · FY2019 · VA · contact PI
AMP Kinase Activation in Calcineurin Inhibitor Nephrotoxicity$0
I01 · FY2018 · VA · contact PI
AMP Kinase Activation in Calcineurin Inhibitor Nephrotoxicity$0
I01 · FY2017 · VA · contact PI
REGULATION OF THYMOCYTE APOPTOSIS BY THROMBOXANE A2$26,661
K08 · FY2000 · AI